Rene Sindlev - Jun 8, 2022 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Director, 10%+ Owner
Signature
/s/ Rene Sindlev
Stock symbol
RENB
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
7/18/2022, 06:02 AM
Previous filing
May 20, 2022
Next filing
Oct 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Other -125K -100% 0 Jun 8, 2022 By RS Arving ApS F1
transaction RENB Common Stock Other -128K -100% 0 Jun 8, 2022 By RS Group ApS F2
holding RENB Common Stock 9.67M Jun 8, 2022 By RS Bio ApS
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid.
F2 On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.